| Autor: |
Abraham, William T., Compton, Steven, Haas, Garrie, Foreman, Blair, Canby, Robert C., Fishel, Robert, McRae, Scott, Toledo, Gloria B., Sarkar, Shantanu, Hettrick, Douglas A. |
| Předmět: |
|
| Zdroj: |
Congestive Heart Failure (15275299); Mar/Apr2011, Vol. 17 Issue 2, p51-55, 5p, 4 Charts, 3 Graphs |
| Abstrakt: |
Congest Heart Fail. The relative sensitivity and unexplained detection rate of changes in intrathoracic impedance has not been compared with standard heart failure (HF) monitoring using daily weight changes. The Fluid Accumulation Status Trial (FAST) prospectively followed 156 HF patients with implanted cardioverter-defibrillator or cardiac resynchronization therapy defibrillator devices modified to record daily changes in intrathoracic impedance in a blinded fashion for 537±312 days. Daily impedance changes were used to calculate a fluid index that could be compared with a prespecified threshold. True positives were defined as adjudicated episodes of worsening HF occurring within 30 days of a fluid index above threshold or an acute weight gain. Unexplained detections were defined as threshold crossings or acute weight gains not associated with worsening HF. Impedance measurements were performed on >99% of follow-up days, compared with only 76% of days for weight measurements. Sixty-five HF events occurred during follow-up (0.32/patient-year). Forty HF events were detected by impedance but not weight, whereas 5 were detected by weight but not impedance. Sensitivity was greater (76% vs 23%; P <.0001) and unexplained detection rate was lower (1.9 vs 4.3/patient-year; P <.0001) for intrathoracic impedance monitoring at the threshold of 60 Ω days compared with acute weight increases of 3 lbs in 1 day or 5 lbs in 3 days and also over a wide range of fluid index and weight thresholds. The sensitivity and unexplained detection rate of intrathoracic impedance monitoring was superior to that seen for acute weight changes. Intrathoracic impedance monitoring represents a useful adjunctive clinical tool for managing HF in patients with implanted devices. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text